Colorectal cancer (CRC) has emerged as a frequently diagnosed disease. Advanced CRCs are highly heterogenous and often evade treatments, building drug resistance and reoccurring.
Click here for original story, Peptidic supramolecular assemblies enhance chemotherapy for colorectal cancer
Source: Phys.org